Solazyme to Showcase Revolutionary Microalgae Food Ingredients, Whole Algal Protein and Whole Algal Flour, at SupplySide West

  Solazyme to Showcase Revolutionary Microalgae Food Ingredients, Whole Algal
  Protein and Whole Algal Flour, at SupplySide West Expo, Booth 32086

Business Wire

SOUTH SAN FRANCISCO, Calif. -- November 1, 2013

Solazyme, Inc. (NASDAQ: SZYM), a leading innovator in microalgae food
ingredients, announced today that they will be showcasing two ingredients,
Whole Algal Protein and Whole Algal Flour, at SupplySide West (SSW) November
14^th-15^th in Las Vegas. The breakthrough Whole Algal Protein is a vegan,
all-natural source of good quality protein that is highly digestible, while
the Whole Algal Flour is a multi-functional, lipid rich ingredient that can
efficiently replace fat sources or enhance mouth feel in a multitude of
different applications, including powder blends, bars and beverages. These
microalgae-derived, whole-food ingredients are also naturally rich in fiber
and micronutrients. Solazyme will be sampling Whole Algal Protein and Whole
Algal Flour applications at Booth 32086.

“We believe Solazyme’s Whole Algal Protein and Whole Algal Flour are
game-changing solutions for the nutrition industry because they operate as
whole-food ingredients, all while providing natural, clean label benefits,”
said Jean-Marc Rotsaert, Chief Operating Officer, Solazyme.

Whole Algal Protein and Whole Algal Flour are products in Solazyme’s suite of
microalgae food ingredients, which also includes a revolutionary food oils
portfolio.

To learn more about Solazyme’s innovative suite of microalgae ingredients,
please visit the sales team at SSW Booth 32086 or visit us at
www.solazyme.com.

About Solazyme, Inc.

Solazyme, Inc. (SZYM) is a renewable oil and bioproducts company that
transforms a range of low-cost plant-based sugars into high-value oils and
innovative microalgal food ingredients. Headquartered in South San Francisco,
Solazyme’s renewable products can replace or enhance oils derived from the
world's three existing sources — petroleum, plants and animal fats.

Solazyme®, the Solazyme logo and other trademarks or service names are
trademarks of Solazyme, Inc.

Forward Looking Statements

This press release contains certain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 about
Solazyme, including statements that involve risks and uncertainties
concerning: Solazyme’s commercialization plans for microalgae food ingredients
and the performance and health benefits of Solazyme’s microalgae food
ingredients. When used in this press release, the words “will”, “expects”,
“intends” and other similar expressions and any other statements that are not
historical facts are intended to identify those assertions as forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. Any such statement may be influenced by a variety of factors, many of
which are beyond the control of Solazyme, that could cause actual outcomes and
results to be materially different from those projected, described, expressed
or implied in this press release due to a number of risks and uncertainties.
Potential risks and uncertainties include, among others: Solazyme’s limited
operating history; its limited history in commercializing products;
implementation risk in deploying new technologies and products; and market
acceptance of its products. Accordingly, no assurances can be given that any
of the events anticipated by the forward-looking statements will transpire or
occur, or if any of them do so, what impact they will have on the results of
operations or financial condition of Solazyme. In addition, please refer to
the documents thatSolazyme, Inc.files with theSecurities and Exchange
Commission, including its Quarterly Reports on Form 10-Q, as updated from time
to time, for a discussion of these and other risks. You are cautioned not to
place undue reliance on forward-looking statements, which speak only as of the
date of this press release.Solazymeis not under any duty to update any of
the information in this press release.

Contact:

Solazyme, Inc.
Genet Garamendi, 650-780-4777
VP, Corporate Communications
press@solazyme.com
 
Press spacebar to pause and continue. Press esc to stop.